SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-19-007745
Filing Date
2019-04-29
Accepted
2019-04-26 17:33:53
Documents
5
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10001223x2_defa14a.htm DEFA14A 40924
2 nc10001223x2_notice01.jpg GRAPHIC 61665
3 nc10001223x2_notice02.jpg GRAPHIC 109193
4 nc10001223x2_notice03.jpg GRAPHIC 40035
5 nc10001223x2_notice04.jpg GRAPHIC 12725
  Complete submission text file 0001140361-19-007745.txt   315591
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32302 | Film No.: 19773022
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10